Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofloxacin-betamethasone versus levofloxacin-betamethasone ear drops for chronic suppurative otitis media
IRCT20170731035409N2Phase 3Completed
- Sponsor
- Zahedan University of Medical Sciences
- Start
- Apr 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in chronic suppurative otitis media (CSOM) comparing Ciprofloxacin + betamethasone ear drops with Levofloxacin + betamethasone ear drops (2 arms). Primary endpoint: Treatment of chronic suppurative otitis media. Started Apr 2016; status: completed.
02
Drugs
ciprofloxacinlevofloxacinbetamethasone
03
Conditions
chronic suppurative otitis media (CSOM)
Beyond the preview
Go deeper on IRCT20170731035409N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170731035409N2.